BioSig Technologies, out of Los Angeles, California, won FDA clearance for its novel PURE EP, a system for gathering, analyzing, and manipulating electrocardiographic and intracardiac data during electrophysiology procedures. The company believes that its system can provide a more detailed and nuanced view of the heart during ablation procedures w (Read more...)